The short-lived success of teicoplanin as an alternative to vancomycin motivated pharmacologic investigators to develop different antibiotic approaches. The failure of glycopeptide antibiotics led ...

1 The pan-Canadian action plan on AMR has outlined priority actions to respond to this threat in Canada, including antimicrobial stewardship.2 Antibiotic treatment duration has historically been fixed ...

An antibiotic developed some 80 years ago before being abandoned and forgotten could again offer exciting new solutions, this time to the emerging threat of drug-resistant superbugs. Half of the ...

Lyfius Pharma has inaugurated its state-of-the-art Penicillin-G (Pen- G) manufacturing facility at Kakinada, Andhra Pradesh with an annual production capacity of 15,000 metric tonnes (MT).

The drugs can wreak havoc on your microbiome. Here’s what may be key to restoring it. Credit...Joyce Lee for The New York Times Supported by By Isobel Whitcomb Q: I was recently prescribed ...

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections (uUTIs). Orlynvah (sulopenem etzadroxil and probenecid) is a broad-spectrum ...

Vaccines against just 23 pathogens could reduce the number of antibiotics needed by 22 percent globally per year, the World Health Organization recently announced. This month, the agency published ...

When bacteria develop resistance to antibiotics, it can be deadly, but researchers have now decoded part of the bacteria's defence mechanism. Imagine falling seriously ill with an infection.

The steady growth in drug-resistant “superbugs” over the last few decades points to a near future in which antibiotics no longer defend us from deadly pathogens. In such a world, modern medicine as we ...

Expert Rev Clin Pharmacol. 2009;2(6):661-672. Several semisynthetic glycopeptide antibiotics for example dalbavancin, telavancin and oritavancin, have been developed to serve as an alternative to ...